Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery
The financing, led by ICONIQ Growth, enables Causaly to accelerate innovation and drive increased adoption of its category-leading AI platform to modernize scientific research.
How Gen AI is Improving Productivity Across Life Sciences R&D Teams
October 29, 2024
Unraveling Mechanisms of Disease Pathogenesis with AI
AI-supported investigations into disease mechanisms offer a transformative approach to understand complex pathologies. By leveraging AI to unlock disease understanding, researchers can identify novel biomarkers and therapeutic targets with unprecedented precision. This not only accelerates the journey from lab to market but also enhances the efficacy and safety of new treatments.
March 6, 2024
Enhance Your Search Sensitivity with AI: Off-Target Effects of BRAF
In contrast to conventional keyword searching techniques, Causaly’s AI can sift through and remove irrelevant data from biomedical searches, offering a more thorough and accurate understanding of entire research landscapes. This not only streamlines knowledge acquisition but ensures accuracy and precision in navigating the biomedical literature.
February 29, 2024